| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $27.1M | +14.1% |
| SG&A Expense | $12.7M | -3.3% |
| Operating Income | -$88.4M | -139.9% |
| Pre-tax Income | -$88.0M | -138.6% |
| Income Tax | $0 | +100.0% |
| Net Income | -$88.0M | -154.9% |
| EPS (Basic) | -$6.16 | -164.4% |
| EPS (Diluted) | -$6.16 | -164.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.4M | -33.5% |
| Current Assets | $59.5M | -32.6% |
| Total Assets | $92.8M | -45.6% |
| Current Liabilities | $6.5M | +47.1% |
| Total Liabilities | $8.6M | +31.4% |
| Stockholders' Equity | $84.2M | -48.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.4M | +1.7% |
| Financing Cash Flow | -$449K | +0.0% |